TriVascular Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
202
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$211M
TriVascular General Information
Description
Operator of a medical device company intended to develop and commercialize innovative technologies to advance invasive treatment of abdominal aortic aneurysms. The company provides product for treatment of abdominal aortic aneurysms and also provides thoracic stent graft systems for the treatment of the thoracic aorta.
Contact Information
Website
www.trivascular.comCorporate Office
- 3910 Brickway Boulevard
- Santa Rosa, CA 95403
- United States
Corporate Office
- 3910 Brickway Boulevard
- Santa Rosa, CA 95403
- United States
TriVascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 25. Merger/Acquisition | 03-Feb-2016 | $211M | Completed | Generating Revenue | ||
| 24. Debt - General | 20-Aug-2015 | Completed | Generating Revenue | |||
| 23. IPO | 16-Apr-2014 | Completed | Generating Revenue | |||
| 22. Restart - Later VC | 12-Dec-2013 | Completed | Generating Revenue | |||
| 21. Restart - Later VC (Series E) | 07-Nov-2013 | Completed | Generating Revenue | |||
| 20. Debt - General | 05-Feb-2013 | Completed | Generating Revenue | |||
| 19. Debt - General | 31-Oct-2012 | Completed | Generating Revenue | |||
| 18. Restart - Later VC (Series D) | 24-Oct-2012 | Completed | Generating Revenue | |||
| 17. Restart - Later VC | 25-May-2012 | $4M | $4M | Completed | Generating Revenue | |
| 16. Restart - Later VC | 22-Feb-2012 | $7.2M | $7.2M | Completed | Generating Revenue |
TriVascular Comparisons
Industry
Financing
Details
TriVascular Competitors (20)
One of TriVascular’s 20 competitors is Merit Medical Systems, a Corporation company based in South Jordan, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merit Medical Systems | Corporation | South Jordan, UT | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Cordis | Private Equity-Backed | Miami Lakes, FL | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Endologix | Corporation | Santa Rosa, CA |
TriVascular Patents
TriVascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3328326-A1 | Endoluminal prosthesis deployment devices and methods | Pending | 30-Jul-2015 | ||
| EP-3328326-A4 | Endoluminal prosthesis deployment devices and methods | Pending | 30-Jul-2015 | ||
| JP-7450662-B2 | Endoluminal prosthesis deployment devices and methods | Active | 30-Jul-2015 | ||
| US-10695206-B2 | Endoluminal prosthesis deployment devices and methods | Active | 30-Jul-2015 | ||
| US-20180296378-A1 | Endoluminal prosthesis deployment devices and methods | Active | 30-Jul-2015 | A61F2/966 |
TriVascular Signals
TriVascular Former Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ABS Ventures | Venture Capital | Minority | ||
| Asset Management Ventures | Venture Capital | Minority | ||
| De Novo Ventures | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| Delphi Ventures (California) | Venture Capital | Minority |
TriVascular FAQs
-
When was TriVascular founded?
TriVascular was founded in 1998.
-
Where is TriVascular headquartered?
TriVascular is headquartered in Santa Rosa, CA.
-
What is the size of TriVascular?
TriVascular has 202 total employees.
-
What industry is TriVascular in?
TriVascular’s primary industry is Surgical Devices.
-
Is TriVascular a private or public company?
TriVascular is a Private company.
-
What is the current valuation of TriVascular?
The current valuation of TriVascular is .
-
What is TriVascular’s current revenue?
The current revenue for TriVascular is .
-
How much funding has TriVascular raised over time?
TriVascular has raised $84.5M.
-
Who are TriVascular’s investors?
ABS Ventures, Asset Management Ventures, De Novo Ventures, Deerfield Management, and Delphi Ventures (California) are 5 of 17 investors who have invested in TriVascular.
-
Who are TriVascular’s competitors?
Merit Medical Systems, Spine Wave, Cordis, Boston Scientific, and Endologix are some of the 20 competitors of TriVascular.
-
When was TriVascular acquired?
TriVascular was acquired on 03-Feb-2016.
-
Who acquired TriVascular?
TriVascular was acquired by Endologix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process